All posts by imreal

Drone Spray Fast Architecture by MuDD Architects Finalist in the Fast Company World Changing Awards 2020


MuDD Architects green roof and vertical gardens

Building with raw local materials and drones will create a revolution in the construction industry and offer better housing for everyone

MuDD Architects offers new ways of building with natural local materials and drones. It allows to build in a matter of days large scale sustainable constructions.

The drone spray fast architecture consists of using drones to spray earthen mortars onto light fromworks to result in vaulted structures or freeform large scale facades in both city centers and remote areas.

Recently MuDD has been refurbishing a derelict facade in Brussels city center while providing for the city some new murals using giant fabric stencils achieved with the drone spray in hours. In addition MuDD will install in Automn 2020 in Lille France the first large scale vertical garden using 3d knitting textile and drone spraying of precise water and nutrients. The advantage of using MuDD’s 3d knittng technology for vertical gardens is that it can be installed in high to access areas such as highway bridges columns or large scale towers.

The drone spray technology offers a new kind of shotcrete allowing freeform and remote constructions to be eased hence more affordable. The technique itself engenders new forms of architecture and highlights earthen raw mortars to be used in very contemporary architectural projects in combination to living plants facades.

One of MuDD stenght lies in the highly multidisciplinary team involved in all their projects, RCtake off, Louvain and Centrale Lille university for the drone development, Euromair for the pump machines and the best engineering firms in the world including AKT II Summum Engineering and Witteveen+ Bos Dubai branch.

Share article on social media or email:

R3 Stem Cell International Now Offering Program for Stroke in Mexico


Stem Cell Treatment Program for Stroke in Mexico

Stem Cell Treatment Program for Stroke in Mexico (888) 988-0515

Treatments at our Mexico Center are not only clinically effective, but very cost effective. Similar treatments in the US or Panama would cost two to four times as much!

R3 Stem Cell International is now offering a new program for stroke patients at its Mexico clinic. The stroke treatment includes upwards of 200 million stem cells and starts at only $8975.

When it comes to stroke therapy, traditional options typically fall short for significant recovery and entail potential risks. When it comes to regenerative therapies, R3 International has had excellent success with stem cell treatment for stroke patients at its Tijuana clinic.

Depending on the patient’s stroke history, treatment will include between 90 million and 200 million stem cells in either a 5 day stay, or with four visits over a year. Initially, patients have a free phone consultation with R3’s licensed and experienced stem cell doctor.

Options for stem cell therapy for stroke in Mexico include either IV therapy, intrathecal, or both. If a patient desires simply a one time treatment, that option is available for just $2975 for 30 million stem cells or $3975 for 50 million cells.

According to R3 CEO David Greene, MD, MBA, “Treatments at our Mexico Center are not only clinically effective, but very cost effective. Similar treatments in the US or Panama would cost two to four times as much!”

The umbilical cord stem cell biologics used at R3’s Mexico clinic are obtained from consenting donors after a scheduled c-section, with no harm to baby or mother. The quality assurance standards at the lab exceed those of the FDA in the US, with safety being of utmost importance.

Once the free phone consultation is completed with R3 International, the patient concierge representative will assist with all travel logistics. The representative will also provide escorted transportation from San Diego to the clinic, which only takes twenty minutes.

Simply call (888) 988-0515 for scheduling and visit https://stemcelltreatmentclinic.com for more information.

Share article on social media or email:

VA Top Docs Proudly Presents May 2020 Approved Providers


VA Top Docs - May 2020

VA Top Docs – May 2020

VA Top Docs and VA Top Dentists are proud to feature the following May 2020 approved providers.

VA TOP DOCS INCLUDE:

ALLERGY, ASTHMA & IMMUNOLOGY

CARDIOLOGY

  • Dr. Omar A. Ali
  • Dr. Neal S. Gaither
  • Dr. Raushan K. Abdula
  • Dr. Jeffrey E. Askew
  • Dr. Tariq A. Aziz
  • Dr. Subash B. Bazaz
  • Dr. Christine D. Bussey
  • Dr. Felix D. Castro
  • Dr. Archer Baskerville
  • Dr. Steven F. Berman
  • Dr. Khalid Abousy
  • Dr. Ather Anis

CRITICAL CARE

DERMATOLOGY

  • Dr. Liana Abramova
  • Dr. William K. Dehart

ENDOCRINOLOGY

FAMILY PRACTICE

  • Dr. Christine M. Aiello
  • Dr. Malarmathi Anbarasan
  • Dr. Jeffrey K. Arbuckle
  • Dr. Elizabeth D. Bakhshi
  • Dr. Rumki Banerjee
  • Dr. John G. Barnes
  • Dr. Beata Barreto
  • Dr. Jeffrey G. Blanchard
  • Dr. D. Mark Bradshaw
  • Dr. John E. Brady
  • Dr. Bruce S. Britton
  • Dr. Tracy M. Buni
  • Dr. Mary A. Cecil
  • Dr. Leanne J. Cha
  • Dr. George Chaconas
  • Dr. Lie-Ping Chang
  • Dr. John A. Clay
  • Dr. Wilson Cook
  • Dr. Gregory J. Craddock
  • Dr. Alicia Cress
  • Dr. Kenneth B. Davis
  • Dr. Todd H. Dehli

GASTROENTEROLOGY

  • Dr. Anant S. Damle
  • Dr. Danielle J. Culbert

GENERAL SURGERY

  • Dr. Matthew L. Brengman
  • Dr. Virginia Chiantella
  • Dr. James W. Cook
  • Dr. Diane R. Cox
  • Dr. Francis Cuozzo

INFECTIOUS DISEASE

  • Dr. Arthur Chutuape
  • Dr. Rahel Amare

INTERNAL MEDICINE

  • Dr. Sheena Abraham
  • Dr. Nazanin Alemzadeh
  • Dr. Tahir Allauddin
  • Dr. Mohit Anand
  • Dr. Dana R. Buchanan
  • Dr. Patricia J. Burkwall
  • Dr. Sean Cowley
  • Dr. Joanne G. Crantz
  • Dr. Carolyn J. Dalldorf
  • Dr. Joseph P. David
  • Dr. Sameh G. Aziz

NEUROLOGY

  • Dr. John R. Baker
  • Dr. Matthew S. Boyce

OB/GYN

  • Dr. Amy Banulis
  • Dr. Christina Baraty
  • Dr. Virginia G. Barber
  • Dr. Siobhan Bertolino
  • Dr. Linda Brown
  • Dr. Sanam E. Campbell
  • Dr. Arshed A. Choudhry

ONCOLOGY / HEMATOLOGY

OPHTHALMOLOGY

  • Dr. Juan A. Astruc Jr.
  • Dr. Gitanjali B. Baveja
  • Dr. J. William Bowles
  • Dr. David M. Bowman
  • Dr. Stephen M. Busch
  • Dr. Melanie J. Buttross
  • Dr. Timothy R. Byrnes
  • Dr. Dal W. Chun
  • Dr. James L. Combs
  • Dr. Gustavo A. Corrales

ORTHOPEDIC SURGERY

  • Dr. Chirstofer Catterson
  • Dr. Nathan W. Coleman
  • Dr. Daniel J. Cuttica

PEDIATRICS

  • Dr. Samantha Ahdoot
  • Dr. Roxanne M. Allegretti
  • Dr. Gayle C. Bates
  • Dr. Joseph A. Bellanti
  • Dr. Ernette Y. Benson-Foulk
  • Dr. Gemila H. Bouber
  • Dr. Laura Charette
  • Dr. Sarah I. Cheema
  • Dr. Rebekah B. Conroy
  • Dr. Cynthia L. Costenbader
  • Dr. Ronda Davis

PHYSICAL MEDICINE / REHABILITATION

PLASTIC / COSMETIC SURGERY

  • Dr. Sharline Z. Aboutanos
  • Dr. Balvant Arora
  • Dr. Saied Asfa
  • Dr. Haven J. Barlow Jr.
  • Dr. Timothy J. Bill
  • Dr. George J. Bitar
  • Dr. Nadia P. Blanchet
  • Dr. Stephen M. Chen

RADIATION ONCOLOGY

UROLOGY

VASCULAR SURGERY

—–

About Us

VA Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in Virginia online in an easy to use format. VA Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

VA Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, e-mail us at info@VATopDocs.com and/or visit http://www.VATopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



Palette Life Sciences Announces European Distribution Expansion for Deflux® and Solesta® for More Than 20 Countries Through Five Leading Distributors and Direct Sales


News Image

We have selected strong partners with deep experience and relationships in the urology and pediatric setting who will help us serve the product and education needs of physicians and hospitals in Europe. – James Leech, Head of Corporate Development, Palette Life Sciences

Palette Life Sciences, a fully integrated global life sciences company dedicated to improving patient outcomes, today announced global distribution expansion for two of Palette’s products, Deflux and Solesta. The expansion provides commercial access to more than 20 countries through five distributors around the globe, while adding direct sales in four additional countries: Cyprus, Greece, Hungary and Portugal.

KEBOMED, a leading European distributor of medical devices and equipment, will distribute the products in France, Sweden, Norway, Finland, Denmark and Iceland. Stratarium Sarl, will commercialize the products in Germany, Austria, Belgium, Germany, Luxembourg, Netherlands and Switzerland leveraging their urology focused subsidiary, RA Distribution. CJ Medical, a UK-based distributor of innovative technologies specializing in surgical and medical devices, will distribute the products in Ireland and the United Kingdom. Grifols, one of the leading companies in the production and sale of plasma-derived medicines and a top distributor of a broad range of products within their country will cover Spain, and GP Dermal, a specialist with deep ties across urology and pediatric call points will serve as the distributor in Italy and Malta.

“This enhanced distribution network allows Palette to ensure our customer and patient needs are adequately met across Europe,” said James Leech, Head of Corporate Development, Palette Life Sciences. “We have selected strong partners with deep experience and relationships in the urology and pediatric setting who will help us serve the product and education needs of physicians and hospitals. Palette and its network of partners are making significant investments within local markets to improve physician access to Palette resources, best management and treatment practices, and renewed product training.”

For more information or to place an order, please contact a Palette Life Sciences representative at eusales@palettelifesciences.com. Contact information for product orders or inquires by distributor are as follows:

KEBOMED: ordre@kebomed.dk

Stratarium Sarl: deflux-solesta@stratarium.com

CJ Medical: office@cjmedical.com

Grifols: jose.sagales@grifols.com

GP Dermal: luigi.galandini@gpdermal.com

About Deflux

Deflux is a minimally invasive, outpatient treatment that has been proven safe and effective in children with vesicoureteral reflux (VUR). VUR is a serious pediatric urinary condition in which urine refluxes from the bladder through one or both ureters toward the kidneys, due to an abnormality at the junction of the ureter and the bladder. Deflux is an injectable gel bulking agent made from two tissue-friendly polysaccharides; Non-Animal Stabilized Hyaluronic Acid (NASHA®) and dextranomer (Dx) microspheres. The product is administered via injection around the ureteral opening to prevent urine reflux. Deflux is indicated in the United States for children with VUR grades II-IV, and is indicated outside of the United States for all grades of VUR. It is the recommended first-line treatment for VUR.1 Separate study results show Deflux is an efficacious long-term (15 – 25 years) treatment option for VUR grade IV2 with up to 93% success rates after a one time injection and no post-injection febrile UTIs (19 month results).3 Deflux is the only minimally invasive VUR treatment approved globally across Australia, Canada, Europe, Latin America, Japan, New Zealand and the United States. For more information, visit http://www.deflux.com

About Solesta

Solesta is a minimally invasive, outpatient treatment for bowel incontinence. Bowel (or fecal) incontinence affects millions of individuals of all ages worldwide. Solesta is an injectable gel made from two polysaccharides; Non-Animal Stabilized Hyaluronic Acid (NASHA®) and dextranomer (Dx) microspheres. The Solesta implant is administered via injection in an outpatient setting without the need for anesthesia.4 Healthcare providers and patients can be confident in the demonstrated durability, safety, and efficacy of Solesta through 36 months. The product has been proven to reduce the number of fecal incontinence episodes, with greater than 80% of patients not requiring retreatment, and enable clinically and statistically significant improvements in quality of life through this time period.5 For more information, visit http://www.mysolesta.com

About Palette Life Sciences AB

Palette Life Sciences is a fully integrated life sciences company. Palette’s products improve patient outcomes in urology and urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. The company’s portfolio of available products includes Deflux®, Solesta® and Barrigel®. Palette Life Sciences moves rapidly to leverage novel applications of existing technologies to create breakthrough medical solutions. This focus enables the company to serve those often overlooked by traditional medical companies and improve patient quality of life. Led by experienced healthcare executives, Palette Life Sciences is headquartered in Stockholm, Sweden with offices in Santa Barbara, California and Dallas, Texas. Learn more at http://www.palettelifesciences.com.

References:

1.    Elder JS, Shah MB, Batiste LR, Eaddy M. Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infection in patients with vesicoureteral reflux. Curr Med Res Opin. 2007;23(4):S15-20.

2.    Stenbäck A, Olafsdottir T, Sköldenberg E, Barker G, Läckgren G. Non-animal hyaluronic acid/dextranomer gel (Deflux®) endoscopic treatment in grade IV VUR results after 15-25 years: durable and effective. J Pediatr Urol. 2020.

3.    Kalisvaart JF, Scherz HC, Cuda S, Kaye JD, Kirsch AJ. Intermediate to long-term follow-up indicates low risk of recurrence after Double HIT endoscopic treatment for primary vesicoureteral reflux. J Pediatr Urol. 2012;9(4)359-365.

4.    Solesta [Package Insert]. Santa Barbara, CA: Palette Life Sciences.

5.    Solesta Post Approval Study Clinical Study Report. December 2019.

Deflux®, NASHA®, Solesta® Palette Life Sciences™ and are registered trademarks. All rights reserved. APM210A

Share article on social media or email:

Pinckney Michigan foot doctor and podiatrist Tomasz Biernacki discusses bunion & hammer toe non-surgery treatment vs. the need for surgery in Livingston County


Pinckney Michigan Dr. Tomasz Biernacki  is a Podiatrist who discusses bunion surgery and hammer toe surgery!

Pinckney Michigan Dr. Tomasz Biernacki is a Podiatrist who discusses bunion surgery and hammer toe surgery!

“It is estimated that the people who develop flat feet and bunion formation can have further knee pain, hip pain and lower back pain. This can lead to permanent arthritis and difficulty wearing shoes or walking.”

Dr. Tomasz Biernacki states that “If bunion, hammer toe and flat foot formation can be caught relatively early, this will prevent permanent arthritis from developing. This can keep the foot from being unable to fit into good supportive shoes in the future.

Dr. Biernacki further states “It is estimated that the people who develop flat feet and bunion formation can have further knee pain, hip pain and lower back pain. This can lead to permanent arthritis and difficulty wearing shoes or walking.”

The podiatrists and foot doctors at Advanced Foot and Ankle Specialists of Pinckney Michigan have developed a treatment algorithm for diagnosing and treating bunion pain with both surgery and without surgery. A bunion is actual the dislocation of a joint called your first metatarsal phalangeal joint.

Dr. Tomasz Biernacki is a practicing podiatric foot and ankle surgeon at Advanced Foot and Ankle specialists of Howell Michigan and Advanced foot and ankle specialists of Howell Michigan and Brighton Michigan pride themselves on providing comprehensive the care and working as a multispecialty team. The four doctors at this practice are on staff at St. Joseph Mercy Hospital Livingston, St. Joseph Mercy Hospital Brighton, and St. Joseph Mercy Hospital Ann Arbor. Working as part of this large multidisciplined team, they can work with internal medicine doctors, primary care doctors, endocrinologists and vascular surgery specialist to provide comprehensive care.

Advanced foot and ankle specialists have four different doctors within their practice: Dr. Tom Biernacki, Dr. John Stevelinck, Dr. Marc Bonanni and Dr. Danielle Meyka-Blanchard. All podiatrists foot doctors are on staff at St. Joseph Mercy hospitals in Ann Arbor, Howell and Brighton Michigan. They pride themselves on serving Livingston County and Washtenaw County.

Share article on social media or email:

Data Analytics Startup, COVEX 2020, Releases New AI Analysis that Predicts Where COVID-19 is Headed Later this Month


News Image

The government is trying to contain future outbreaks by physically tracking people and calling them. That won’t work when it comes to containment. If we’re going to contain this Coronavirus, we need to physically track people using technology.

The data analytics startup, COVEX 2020, has released the first AI analysis that looks into how the George Floyd protests across the country will likely impact COVID-19 infection rates over the following weeks.

The data analysis used public data from John Hopkins University and proprietary machine learning from COVEX 2020 to project where infection rates will likely be on June 23rd. The analysis, which took place on June 10th, suggests a grim outlook for New York City, Chicago, Washington, DC, Los Angeles and Atlanta.

The analysis suggests New York City will see a 5.5 percent increase in infection rates starting on June 23rd, or an additional 14,496 new cases. In comparison, the 10-days leading up to the analysis showed infection rates were steadily slowing with a rate increase of less than 2 percent.

The data analysis also suggests Los Angeles will see the largest infection rate increase of the major protest cities. LA’s projected infection growth will be 8.46 percent on June 23rd – followed by Chicago at 8.22 percent; Washington, DC at 7.99 percent and Atlanta at 6.95 percent.

The CEO of COVEX2020, Christopher Malter, said the data analysis was intended to showcase how AI and analytics can help health officials contain the Coronavirus until a vaccine is created.

“The government is trying to contain future outbreaks by physically tracking people and calling them. That won’t work when it comes to containment,” said Malter. “If we’re going to contain this Coronavirus, we need to physically track people using technology. The AI is here and ready to use. Right now, there’s no way to alert those protesters if they were in close proximity to people who were carrying COVID-19. But using this enterprise software, we can know and communicate to these potential carriers faster than physically calling them up.”

Current government plans call for hiring 100,000-300,000 workers to physically track patients who tested positive at a cost of $65,000/year per worker.

A Closer Look at Future COVID-19 Cases

New York City was beginning to plateau in cases before the protests started, but by the end of June, there are projected to be 277,889 confirmed cases.

Los Angeles is slightly more manageable with a projected 80,595 confirmed cases by the end of June.

Washington DC’s confirmed cases are projected to be 13,122 total cases.

Chicago’s Cook County is projected to have 107,796 total cases by June 24th and 143,461 total cases by July 22nd.

States with the Highest Projected Number of Cases on June 24th

New York – 480,189 (an increase of over 110,000)

New Jersey- 216,142 (an increase of over 55,000)

California- 151,832 (an increase of nearly 40,000)

Illinois- 166,243 (an increase of 46,000)

Massachusetts- 137,594 (an increase of 40,000)

Malter said their data analytics team is now in the process of studying how socio economics, race and neighborhoods play a role in determining who is more or less likely to test positive for COVID-19.

“On the surface, we’ve already observed a relationship that resembles the digital divide,” said Malter. “Our team is digging deeper but it appears factors like access to high speed Internet appears to be a predictive indicator to your chances of testing positive or negative to COVID-19. We’ve already observed how predominant neighborhoods of color are more likely to have higher cases of COVID-19 infections. Our data is also suggesting that it’s not just limited to race but also income and Internet connectivity.”

ABOUT COVEX 2020

COVEX 2020 is an AI company dedicated to developing real time enterprise solutions connecting customers with end users through smart technology. COVEX 2020 has formed partnerships with Stanford and Oxford University, RWJ Barnabas Medical Center, Pacira Pharmaceuticals Inc., and Fintel Labs.

Media Contact

Mark Macias

mmm@maciaspr.com

646-770-0541

Share article on social media or email:

Safentri launches a comprehensive return-to-workplace solution for safe facility entry and crowd management


“In the early days of the pandemic we recognized that a comprehensive return-to-work strategy was going to require a legal and compliance component. Increasingly companies are realizing that protecting their organization requires legally sound processes and protocols.” said David Essary, Co-Founder

Covid-19 has challenged employers and facility operators to bring their workers, vendors, and customers back to their facilities safely, while ensuring their security and privacy. A group of veterans of HR technology, software development and law came together to create Safentri to solve for this challenge.

Safentri allows organizations to create responsible return-to-work (or play) policies and manage liability and compliance more effectively. The solution’s inherent flexibility and universally accessible platform can be applied by employers as part of a return-to-workplace strategy, by healthcare, government offices, and others to manage employees, visitors and vendors. Safentri can be used by sports leagues, education and faith organizations to help foster a safe environment.

“A few weeks into the Covid-related shutdown, we began to think about how businesses would approach a return-to-workplace strategy. We quickly realized that it was the perfect application for ONEplatform, ONEtechnology’s No-code Application Platform as a Service. In under 7 weeks our team built a robust and customizable platform. We believe that Safentri’s comprehensive process and protocols are superior to any solution in the market today,” said Kevin Austin, Co-Founder at Safentri.

The Safentri platform is a progressive web app (PWA), making it universally accessible by any device and any OS. No downloads or updates required – ever. The durable API framework provides a broad range of import/export options, such as connecting to third-party testing processes and existing security architecture. The AWS hosted environment is scalable and secure (data is fully encrypted in transit & at rest), and the no-code ONEplatform allows Safentri to adapt quickly as conditions change.

“We quickly learned that a primary concern for a return-to-work solution was the legal and compliance uncertainty,” says Co-Founder David Essary. “The team’s experience in the HR, healthcare and insurance sectors enabled us to add one of the country’s premier labor and employment law firms, Hall Booth Smith to the partnership, providing legal expertise to navigate an evolving compliance landscape.”

The Safentri solution incorporates key compliance standards, including HIPAA, OSHA/EEOC, DOL & ADA, and adheres to guidance from the CDC. System administrators have broad flexibility to customize the health validation criteria they require in their specific environment.

The easy-to-use app quickly validates a person’s health status and compliance to facility requirements for entry, generates entry credentials, including digital or print entry badges, and provides a complete digital chain of custody record of all documents and interactions to protect the proprietor in the event of legal action.

One healthcare company CEO summed it up this way: “We need to protect our workforce as they transition back to work, but we must do it carefully to protect the company from legal liability. Safentri is easy to use, and the suite of services is very comprehensive to serve our needs. The connection to industry-leading legal resources was also a significant plus.”

Essary concludes, “What started as a return-to-work assessment app for employers has expanded to allow us to quickly respond to the market with additional capabilities, such as vendor/visitor management, ongoing safety training, facilitation of COVID-19 testing, and access to personal protective equipment (PPE). We are engaging with organizations from various industries.”

About Safentri

Formed in 2020, Safentri – powered by ONEtechnology, is a Georgia-based team of professionals from the technology, HR, insurance, legal and healthcare space who have come together to apply our experience to create an end-to-end return-to-work solution.

About ONEtechnology

An Atlanta-based team of successful technology entrepreneurs have authored ONEplatform, a full-featured, high-control, visual declarative application designer & renderer used to build progressive web applications (PWA’s) with pixel perfect UI/UX. The no-code, collaborative, browser-based platform enables the rapid creation and delivery of hyper-responsive apps that accelerate performance with payloads 30-50% lighter than traditional web apps. ONEplatform’s powerful workflow and orchestration capabilities are on par with sophisticated BPM solutions – without writing any code. ONEplatform’s open, scalable internet technologies enable the development of enterprise-grade web applications in hours what would otherwise take weeks or months using traditional development tools.

About Hall Booth Smith

Established in 1989, Hall Booth Smith, P.C. (HBS) is a full-service law firm with offices in Alabama, Georgia, Florida, North and South Carolina, New Jersey, New York, and Tennessee. Experienced across a wide range of legal disciplines, HBS prides itself on providing knowledgeable, proactive, client-specific counsel to individuals, domestic and international corporations, state and federal agencies, and nonprofit organizations. Included within our regulatory and specialty practice area are labor and employment, healthcare and government affairs.

Media Contact

Safentri, Inc.

Mark Hufham mark.hufham@safentri.com

Share article on social media or email:

Elgia Therapeutics Announces New Funding to Develop Novel Treatments for Chronic Inflammatory and Fibrotic Diseases


Elgia Therapeutics is committed to developing novel drugs for the treatment of chronic inflammatory and fibrotic diseases. We’re delighted to welcome new investors as we pursue this mission.” said Professor Alan Saltiel, Chief Executive Officer of Elgia Therapeutics

Elgia Therapeutics, a biotechnology company that aims to eliminate low-grade inflammation, today announced seed funding that will accelerate the development of novel treatments for chronic inflammatory and fibrotic diseases.

The funding was led by Viva BioInnovator, the specialized investment and incubation arm of Shanghai-based Viva Biotech Holdings, with participation from ChangRong Capital.

“Elgia Therapeutics is committed to developing novel drugs for the treatment of chronic inflammatory and fibrotic diseases. We’re delighted to welcome new investors as we pursue this mission.” said Professor Alan Saltiel, Chief Executive Officer of Elgia Therapeutics. “Effectively combating low-grade inflammatory diseases like NASH will require drugs that directly and specifically target energy imbalances, focusing on the genes/proteins that are specific effectors of pathological pathways responsible for sustaining lipid accumulation, fibrosis and cellular death.”

“It is gratifying to see that our cutting edge science and technology attracts interest and investments.” added Professor Ariel Feldstein, Chief Scientific Officer of Elgia Therapeutics. “This capital infusion from Viva BioInnovator is a good harbinger of the regard for our science from the innovation partnership community.”

Dr. Zhixiong Ye, Chief Scientific Officer of Viva Biotech, said: “Elgia has world-leading scientists in the biology of innate immunity, inflammation and wound healing responses. We are delighted to partner with them to develop novel treatments for chronic inflammatory and fibrotic diseases.”

About Elgia Therapeutics

Elgia Therapeutics is a newly established venture-backed biotech company pursuing novel approaches for the treatment of chronic inflammatory and fibrotic diseases. Elgia was founded by UCSD and UCSF scientists Alan Saltiel, Ariel Feldstein, Michael Karin, Michelle Arkin, and Adam Renslo, who are world leaders in the biology of innate immunity, inflammation and wound healing, as well as in the biochemistry and pharmacology of key enzymes that control inflammation and cell demise. Leveraging the expertise of our founders, Elgia will use high throughput chemical screening coupled with structure-based design to discover and develop novel inhibitors of these targets. Visit Elgiatherapeutics.com for more information.

About Viva BioInnovator

Viva BioInnovator (VBI) is the investment division of Viva Biotech Holdings (1873.HK). We are solely dedicated to the identification and success of early-stage biotech start-ups for Viva’s incubation, equity-for-service, and investment platforms. Our commitment is to operate a collaborative platform for innovative biotech companies from around the world, and for anyone aiming to develop an idea with transformative or strong potential. Visit vivabioinnovator.com for more information.

Share article on social media or email:

Global Lyme Alliance Welcomes Three New Members to its Board


News Image

The three new members will be an asset to GLA as we continue our mission to conquer Lyme and make a difference in the lives of those suffering from tick-borne illnesses or who are at risk.

Global Lyme Alliance (GLA), the leading 501(c)(3) dedicated to conquering Lyme and other tick-borne diseases through research, education, awareness, and patient services, announced today the appointment of three new members to its Board of Directors. The new members are Karen Kelly, Scott Moresco and Brent Patry.

“We are pleased to welcome Karen, Scott and Brent to our board,” said Scott Santarella, GLA’s CEO. “They come to us with diverse experiences, valuable insights, and a passion for GLA’s mission and vision. We are fortunate to have them by our side as GLA continues to change the paradigm of Lyme disease understanding, treatment and management around the globe.”

GLA leads the fight against Lyme and other tick-borne diseases by initiating and investing in innovative research to find a reliable diagnostic test and new improved treatments. At the same time, GLA has increased Lyme and tick-borne disease awareness through a wide variety of education and prevention programs, including its Be Tick AWARE and global Lyme Education Ambassador Program (LEAP). “The three new members will be an asset to GLA’s Board and the organization as a whole as we continue our mission to conquer Lyme and make a difference in the lives of those suffering from tick-borne illnesses or who are at risk,” said Santarella.

The new Board members are:

-Karen Kelly, an entrepreneur, philanthropist, and a staunch advocate dedicated to raising Lyme awareness and improvements in diagnostics and treatments. Both Karen and her husband, Bob, who suffers from the tick-borne disease, were honored at GLA’s NYC Gala in 2019. Bob is owner of New Jersey-based Roadtex Transportation Management Corp., where Karen plays a role in strategic planning, operations and finance. She is also an accomplished networker and has now turned her considerable skills to expanding GLA’s reach.

-Scott E. Moresco, CPA, is West Region Service Line Leader in KPMG’s Merger & Acquisitions Tax practice in Chicago. In his work he focuses on the taxation of transactions involving U.S. and foreign corporations. Moresco’s daughter, Alex, has suffered from Lyme for several years and is an active and dedicated volunteer for GLA. The Moresco family has been the lead supporters of several fundraisers for GLA in the Chicago area.

-Brent Patry is Managing Director and Global Head of BlackRock Private Capital Markets. He is responsible for originating new investments and for the various financing activities across the Alternatives platform at BlackRock, which includes Credit, Private Equity, Infrastructure, Real Estate and Solutions businesses.  Patry has over 27 years of experience leading, managing and growing alternative asset origination businesses. Prior to joining BlackRock, Patry held a number of management roles at Credit Suisse. Originally from Toronto, he now lives in New York City.

More information about GLA’s board can be found at GLA.org.

###

ABOUT GLOBAL LYME ALLIANCE

Global Lyme Alliance is the leading 501(c)(3) organization dedicated to conquering Lyme and other tick-borne diseases through research, education, awareness, and patient services. GLA has gained national prominence for funding some of the most urgent and promising research in the field, while expanding education and awareness programs for the general public and physicians. We support those around the globe in need of information about tick-borne diseases, seeking a Lyme treating physician, and through the first Lyme-specific peer-to-peer mentor support program. Learn more at GLA.org.

Share article on social media or email:

Carnegie Dental Wellness Announces New Hybrid-Responsive Website


Carnegie Dental Wellness

We provide general dentistry services and are experts in restorative and cosmetic treatments. Your smile and dental health are so very important to your well being. We are here to help you look and feel your best

Carnegie Dental Wellness of New York, NY is pleased to announce the launch of its new Hybrid-Responsive website: https://www.cnbdental.com.

The new Carnegie Dental Wellness site has a clean, bright aesthetic reflecting the feel of this modern New York City dental practice. Look beyond the site’s appearance and you’ll find a seamless online experience built upon the latest research in usability and web design. The uncluttered layout makes finding information intuitive and simple. Patients can learn about treatment options, request appointments, find out more about the practice, and read patient testimonials all with a few clicks or taps to the screen.

As Dr. Constantina Bacopoulou, owner of Carnegie Dental Wellness, explains, “We provide general dentistry services and are experts in restorative and cosmetic treatments. Your smile and dental health are so very important to your well being. We are here to help you look and feel your best.”

What makes the Carnegie Dental Wellness website particularly useful for patients is its ability to adapt to their devices. The site is equally responsive on desktops, laptops, tablets, and smartphones. This means that it’s just as easy for patients to access information at home as it is when they’re on-the-go. No matter where they are, they can connect with the practice, send a question via the contact form, or read more information about a dental condition they have.

Carnegie Dental Wellness isn’t just innovating in its approach to website design — it’s also taking a proactive approach to COVID-19 that embraces the latest research on how the coronavirus is transmitted. In addition to this, Carnegie Dental Wellness is a boutique dental practice with a single dentist, meaning there’s never a crowded waiting room full of patients and there aren’t dozens of dentists, hygienists, and staff members in the office at all times, making it difficult to observe social distancing protocols.

About Constantina Bacopoulou, DDS

Dr. Bacopoulou earned her Doctor of Dental Surgery Degree from New York University before completing fellowships in aesthetic and implant dentistry. Although her practice specializes in cosmetic dentistry, she performs a full range of dental services for her patients. She has served as faculty at the NYU College of Dentistry and is a current member of the American Dental Association, American General Dentistry, and the American Academy of Implant Dentistry.

About Carnegie Dental Wellness

Carnegie Dental Wellness is a boutique dental practice located in New York City that offers general dentistry, Invisalign, cosmetic dentistry, and dental implant services. The practice takes a holistic approach to dental care and prides itself on cosmetic and restorative dental procedures that improve both the function and appearance of patients’ smiles. To learn more or request an appointment, visit the new website at https://www.cnbdental.com or call (212) 582-6617. The practice is located at 134 W. 58th St., Suite 105, New York, NY 10019.

Share article on social media or email: